Diagnosis and management of parapneumonic effusions and empyema
- PMID: 17990232
- DOI: 10.1086/522996
Diagnosis and management of parapneumonic effusions and empyema
Abstract
Approximately 1 million patients develop parapneumonic effusions (PPEs) annually in the United States. The outcome of these effusions is related to the interval between the onset of clinical symptoms and presentation to the physician, comorbidities, and timely management. Early antibiotic treatment usually prevents the development of a PPE and its progression to a complicated PPE and empyema. Pleural fluid analysis provides diagnostic information and guides therapy. If the PPE is small to moderate in size, free-flowing, and nonpurulent (pH, >7.30), it is highly likely that antibiotic treatment alone will be effective. Prolonged pneumonia symptoms before evaluation, pleural fluid with a pH <7.20, and loculated pleural fluid suggest the need for pleural space drainage. The presence of pus (empyema) aspirated from the pleural space always requires drainage. Fibrinolytics are most likely to be effective during the early fibrinolytic stage and may make surgical drainage unnecessary. If pleural space drainage is ineffective, video-assisted thoracic surgery should be performed without delay.
Similar articles
-
Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.Indian J Chest Dis Allied Sci. 2008 Jul-Sep;50(3):277-82. Indian J Chest Dis Allied Sci. 2008. PMID: 18630794 Review.
-
Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.Acta Med Indones. 2012 Jul;44(3):258-64. Acta Med Indones. 2012. PMID: 22983084 Review.
-
Parapneumonic pleural effusion and empyema.Respiration. 2008;75(3):241-50. doi: 10.1159/000117172. Epub 2008 Feb 15. Respiration. 2008. PMID: 18367849 Review.
-
Parapneumonic effusions and empyema.Clin Chest Med. 1985 Mar;6(1):55-62. Clin Chest Med. 1985. PMID: 3847302
-
Diagnosis and management of parapneumonic effusions.Semin Respir Crit Care Med. 2008 Aug;29(4):414-26. doi: 10.1055/s-2008-1081284. Semin Respir Crit Care Med. 2008. PMID: 18651359
Cited by
-
Biochemical analysis of soft tissue infectious fluids and its diagnostic value in necrotizing soft tissue infections: a 5-year cohort study.Crit Care. 2024 Nov 1;28(1):354. doi: 10.1186/s13054-024-05146-0. Crit Care. 2024. PMID: 39487543 Free PMC article.
-
Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.BMC Infect Dis. 2008 Jul 11;8:90. doi: 10.1186/1471-2334-8-90. BMC Infect Dis. 2008. PMID: 18620553 Free PMC article.
-
Analysis of clinical characteristics and risk factors of community-acquired pneumonia complicated by parapneumonic pleural effusion in elderly patients.BMC Pulm Med. 2023 Sep 20;23(1):355. doi: 10.1186/s12890-023-02649-4. BMC Pulm Med. 2023. PMID: 37730573 Free PMC article.
-
Effects of coexisting pneumonia and end-stage renal disease on pleural fluid analysis in patients with hydrostatic pleural effusion.Chest. 2013 Jun;143(6):1709-1716. doi: 10.1378/chest.12-2221. Chest. 2013. PMID: 23288037 Free PMC article.
-
Mortality among patients with pleural effusion undergoing thoracentesis.Eur Respir J. 2015 Aug;46(2):495-502. doi: 10.1183/09031936.00217114. Epub 2015 Apr 2. Eur Respir J. 2015. PMID: 25837039 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
